Cervical cancer: Part I human papilloma virus vaccination in Taiwan
Adult
Human papillomavirus
Papillomavirus Infections
Vaccination
Taiwan
Uterine Cervical Neoplasms
Human Papillomavirus Viruses
Gynecology and obstetrics
Recommendations
Middle Aged
03 medical and health sciences
0302 clinical medicine
Cervical cancer
RG1-991
Humans
Female
Papillomavirus Vaccines
Early Detection of Cancer
DOI:
10.1016/j.tjog.2024.04.005
Publication Date:
2024-05-25T15:38:30Z
AUTHORS (6)
ABSTRACT
A significant decline in both incidence and prevalence of cervical cancers after widespread-introducing screening strategy by Papanicolau test (Pap test) has been found the world, but cancer is still one most common female cancers, reporting fourth also leading causes to result main women-associated morbidity mortality, particularly for those women living low- middle-income countries. Cervical important health concerns directly destroying global health-care system, partly because not only increasing disability either secondary diseases themselves victims or mediated treatment-related adverse events survivors acting as a cause death diseased patients worldwide, alarming urgent need do something minimize catastrophic diseases-related heavy socioeconomic burden. It fortunate that preventable disease, based on its strong association with human papillomavirus (HPV) infection (more than 95%), high-risk HPV (HR-HPV) high possibility detecting before development well an effective prevention vaccination. That why WHO (World Health Organization) considers public problem attempts accelerate elimination program three-pillar approach (90:70:90% targets), including (1) 90% girls are fully vaccinated vaccine 15 years age; (2) 70% screened high-performance 35 45 age precancerous lesions treated early; (3) identified receive appropriate adequate treatment. Herein, this review focuses vaccination Part I, recommendations Taiwan government's policy
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (79)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....